# Build Log: Inpatient Opioid Tool

## v9.6.0 - Architectural Hardening & Safety Service

**Date:** Jan 21, 2026
**Focus:** Performance, Type Safety, & Validation Integrity

* **Safety Service Extraction**:
  * **Stateless Validation**: Extracted all clinical validation logic (Renal, Hepatic, Pregnancy, Safety Gates) from the `AssessmentStore` "God Class" into a stateless `SafetyAdvisoryService`.
  * **AssessmentSnapshot**: Introduced an immutable `AssessmentSnapshot` struct to pass data to the validation engine, decoupling state mutation from logic execution.
  * **Bug Fix**: Resolved a critical issue where `validateSafetyGates` warnings were being overwritten by subsequent logic, ensuring all blocking alerts are now persistently visible.

* **Enum-Based Taxonomy Refactor**:
  * **OpioidMolecule**: Replaced all string-based drug identification (e.g., `if name.contains("Morphine")`) with a type-safe `OpioidMolecule` enum.
  * **Impact**: hardened the codebase against "Magic String" typos and enabled reliable, compiler-checked safety logic for complex filters (Renal/Hepatic).

## v9.5.0 - Safety Alert Severity (v2.0)

**Date:** Jan 20, 2026
**Focus:** UI Hierarchy & Alert Fatigue

* **Severity Engine**:
  * **Critical (Red Hat)**: Implemented "Forced Open" logic for life-safety alerts (e.g., Renal Cliff, Hepatorenal Syndrome). These cannot be collapsed by the user.
  * **Standard (Amber)**: Collapsible warnings for stewardship/optimizations.
* **Component Library**:
  * Created `SafetyAlertsView` to standardize alert rendering across the application.

## v6.13.0 - Clinical Logic Refinement & Hardening

**Date:** Jan 20, 2026
**Focus:** Renal/Hepatic Precision & Pediatrics

* **Clinical Logic**:
  * **Renal Cliff Fix**: Refined Morphine logic. Now allows Morphine with "Caution (-25-50%)" for eGFR 30-60 (previously a hard block). Maintains hard block for Dialysis/eGFR < 30.
  * **Buprenorphine**:
    * **Neuropathic**: Explicitly prioritizes Transdermal/Buccal formulations.
    * **Stacking Risk**: Added "Competition Risk" warning for high-affinity agonist breakthrough.
  * **Fentanyl**: Added "12-24h Latency" warning for Patch recommendations.
  * **Tramadol**: Added Serotonin Syndrome warning loop.
  * **Ketamine**: Added Psych History check (Dysphoria risk).
* **Safety Gates**:
  * **Hepatic NSAID Block**: Implemented hard gate removing all NSAID adjuvants in Hepatic Failure (Coagulopathy Risk).
  * **Pediatric Lock**: Ported `PediatricLockScreen` to the Risk Assessment tab to prevent adult-dose generation for minors.

## v6.12.7 - OUD Protocol Refinement

**Date:** Jan 9, 2026
**Focus:** Safety Gates & Evidence Alignment

* **Clinical Logic (`ClinicalData.swift`)**:
  * **Micro-Induction Threshold**: Fentanyl induction now only triggers Micro-Induction if COWS < 13.
  * **Safety Gates Removed**: removed "Liver Failure" and "Acute Pain" as contraindications for Buprenorphine; they now map to Standard Induction (Safe).
  * **Pregnancy Management**: Updated standard of care to "Buprenorphine/Naloxone (Suboxone)" (Combo preferred over Mono).
  * **Terminology**: Renamed "Macrodosing" to "High-Dose Initiation" for ER/Inpatient contexts.
* **Aberrant Behavior Protocol (ASCO vs CDC)**:
  * **Interactive Module**: Created `AberrantBehaviorView` for responding to yellow/red flags.
  * **Cancer Context**: Implemented logic bifurcation for Yellow Flags:
    * **Cancer**: "Restructure (No Taper)" (ASCO 2016/NCCN 2025).
    * **Non-Cancer**: "Tighten & Consider Taper" (CDC 2022).
  * **Integration**: Auto-detects context from Assessment indication (`.cancer`).
* **Testing (`ClinicalValidationEngine`)**:
  * Updated Test Cases O1-O10 to reflect the new logic (O2 Fentanyl Micro threshold, O6/O7 Safety).

## v6.12.6 - Fentanyl Conversion Update

**Date:** Jan 9, 2026
**Focus:** Guideline Alignment (NCCN/FDA)

* **Conversion Logic**:
  * **Fentanyl Transdermal**: Updated conversion factor from 2.4 to **2.0** (25 mcg/hr = 50 MME) to match NCCN 2025 and FDA guidelines.
  * **Data Source**: Updated `drug_database.json` with new factor and "High" evidence quality source.
* **Validation**:
  * Updated Test Case **M2** to expect 50 MME (±1.0).

## v6.12.5 - Clinical Guideline Overhaul

**Date:** Jan 9, 2026
**Focus:** CPG Updates (Pericarditis, Gout, PCA)

* **Protocols**:
  * **Pericarditis**: Added Colchicine + Aspirin/NSAID regimens; updated corticosteroid warnings.
  * **Gout**: Updated acute flare management (Colchicine loading dose, Prednisone alternative).
  * **PCA Logic**: Refined demand dose/lockout intervals based on latest safety data.
* **Drip Logic**:
  * **Hydromorphone/Fentanyl**: Refined conversion factors for continuous infusions.
  * **Monitoring**: Added specific PRODIGY-based monitoring triggers for high-risk profiles.

## v6.12.0 - PRODIGY & Drug Database

**Date:** Jan 4, 2026
**Focus:** Risk Stratification & Data Architecture

* **Risk Engine**:
  * **PRODIGY Score**: Corrected point values for Male sex and CHF to align with Khanna et al.
  * **Validation**: Added regression tests for PRODIGY scoring.
* **Architecture**:
  * **Drug Database**: Migrated hardcoded drug data to `drug_database.json` for centralized management.
  * **Infusion Logic**: Implemented `InfusionDuration` to distinguish between Acute (0.3x) and Continuous (0.12x) Fentanyl factors.

## v6.11.0 - Library & Search Enhancements

**Date:** Jan 7, 2026
**Focus:** Usability & Metadata

* **Features**:
  * **Tag Integration**: Integrated drug tags (e.g., "Full Agonist", "Safe in Renal Failure") into the library search engine.
  * **Visual Badges**: Added color-coded badges to drug reference cards for quick safety identification.

## v6.10.1 - Calculator Architecture Refactor

**Date:** Jan 4, 2026
**Focus:** Data Safety & Sandbox Isolation

* **Refactor**:
  * **Decoupled Stores**: Implemented `CalculatorInputs` protocol to decouple `CalculatorStore` from the global `AssessmentStore`.
  * **Transactional Logic**: Calculator now operates as a true sandbox (inputs seed from Assessment but never write back), preventing cross-patient state contamination.

## v6.10.0 - Safety Gates Implementation

**Date:** Jan 4, 2026
**Focus:** Critical Safety Controls

* **Safety Gates**:
  * **Pediatric Lock**: Hard stop interface for patients < 18 years old.
  * **Dirty State Checks**: Implemented tab switching warnings to prevent accidental data loss.
  * **Reset Controls**: Added global "Reset" functionality to clear the active assessment.

## v6.9.0 - UI "Clinical Modern" Overhaul

**Date:** Dec 31, 2025
**Focus:** Aesthetic Alignment & Code Cleanup

* **UI Design**:
  * **Theme Update**: Aligned iOS app with the "Clinical Modern" web aesthetic (Tea/Green palette, clean typography).
  * **Component Refactor**: Updated `CalculatorView` and `Theme.swift` to use the new design system.
* **Codebase Hygiene**:
  * Removed dead code/artifacts from legacy implementations.
  * Cleaned up `ReferenceItem` naming conflicts (`ClinicalReferenceItem`).

## v6.8.0 - Codebase Hygiene & Build Stabilization

**Date:** Dec 18, 2025
**Focus:** Build Repair & Debt Reduction

* **Stabilization**:
  * **Build Fixes**: Resolved critical compilation errors (unbalanced braces, unescaped characters) that were preventing successful builds.
  * **Dead Code Removal**: Aggressively pruned unused legacy files and functions to reduce technical debt.
  * **Syntax Corrections**: Fixed syntax errors across the core module to ensure a clean "Zero-Warning" build state.

System Polish & Safety Hardening
Changes Implemented

1. Refined Input Buttons "Messy UI" Fix
Problem: The old "pill" buttons wrapped unevenly, creating jagged edges and visual clutter.
Solution: Implemented a dual-mode SelectionView.
≤ 3 Options: Renders as a single Segmented Control (sliding bar). Visually cleaner for simple toggles (e.g., Renal Function).
4+ Options: Renders as a Uniform Grid (2 columns). Buttons now have fixed heights, creating a perfectly aligned table structure.
2. Risk Assessment Keyboard Safety
Problem: The keyboard covered the "Age" input, and there was no way to scroll it into view.
Solution: Added ScrollViewReader and @FocusState to RiskAssessmentView.
Behavior: Tapping "Age" now keeps the field visible. The global "Done" toolbar button works everywhere.
3. Data Flow Fix
Problem: Results summary showed "??F" instead of the patient's age.
Root Cause: While AssessmentStore was correct, the generatedSummary string logic in RiskAssessmentView wasn't triggering a refresh on the Age field edit.
Verification: Direct binding in the TextField combined with the @EnvironmentObject store ensures the UI layout updates and passes the value reliably.
4. Calculator "Screen Shake" Fix
Problem: High-risk warnings appeared with a default animation that "shook" the entire screen violently.
Solution: Applied a customized .transition(.opacity) to the CollapsibleWarningCard.
Result: Alerts now fade in/out smoothly, creating a stable, professional feel.
5. Critical Safety Review (Monograph)
Problem: The "Visual Potency Guide" was ambiguous (PO vs IV), and Fentanyl showed a confusing "Oral Bioavailability" bar.
Solution:
Labeling: Changed "PO Profile" -> "ORAL (PO)" (Teal) and "IV Profile" -> "INTRAVENOUS (IV)" (Red/Rose).
Fentanyl Guard: Hard-coded logic to HIDE the Oral Bioavailability bar if the drug is Fentanyl. This prevents users from thinking there is a relevant oral conversion for IV Fentanyl.
6. SOAP Consult Note Generator
Feature: Added a "Consult Note" generator to the Assessment Details.
Value: Enables clinicians to instantly generate a formatted "Pain Management Consult Note" (Subjective, Context, Assessment, Plan) ready for EMR paste.
UI: Added a "Copy Note" button and a monospaced preview in the Details sheet.
7. Core Logic & Calculator Repairs
MME Calculator Zero-State Fix: Diagnosed ConversionService loading failure. Verified robust Bundle Search logic (Main vs Class Bundle) and added Debug-only absolute path fallback to ensure
drug_database.json
 loads reliably in all environments.
Bioavailability Logic Polish: Hidden "Oral Bioavailability" bar for IV/SQ-focused drugs (e.g. Fentanyl, IV Morphine) to prevent clinical confusion.
Risk Score Standardization: Updated OIRD thresholds to align with clinical standards:
0-10: Low (Green)
11-19: Intermediate (Orange)
20+: High (Red)
Verification Steps
Launch Assessment:
Verify Standardized Buttons (Grid vs Segmented).
Verify Keyboard Avoidance on Age input.
Verify Age Data appears in the summary.
Check Risk Header: Verify Score 0-10 is Green, 11-19 Orange, 20+ Red.
Calculator:
Zero State Test: Enter "10" for Morphine. Verify Header updates instantly.
Trigger a High Dose warning. Verify Smooth Fade, no shake.
Monograph (Pharmacy):
Open "Morphine": Check bold ORAL (PO) vs INTRAVENOUS (IV) headers.
Open "Fentanyl": Confirm NO "Oral Bioavail" bar exists.
Consult Note:
Complete an assessment. Tap Details.
Scroll to "CONSULT NOTE".
Tap Copy Note. Paste into Notes app. Verify Header, Subjective, Assessment, and Plan structure.
8. Calculator Logic Repairs
Fentanyl IV Drip Fixed: Added explicit "Fentanyl (IV Drip)" input which correctly uses the Continuous Infusion Factor (0.12) instead of the Acute factor (0.3).
Buprenorphine Exclusion: Implemented logic to catch Factor 0 (Excluded) drugs and display "EXCLUDED (See Warnings)" on the receipt instead of failing silently.
Verification Steps (Added)
Calculator Logic:
Fentanyl Drip: Check for "Fentanyl (IV Drip)" input.
Buprenorphine: Enter "Butrans". Verify Receipt says "EXCLUDED".
9. Fentanyl Safety Hardening
Patch Reduction Safety: Fixed critical bug where Fentanyl Patch targets ignored the safety slider. Now correctly uses reducedMME (e.g., 50% slider -> 50% lower patch recommendation).
IV Label Clarity: Renamed Fentanyl IV target to "Fentanyl (IV Push (Acute))" to prevent confusion with continuous infusions.
Verification Steps (Added)
Fentanyl Patch Safety:
Input: 100mg PO Morphine (100 MME).
Slider: Set to 50%.
Verify: Fentanyl Patch target recommends 25 mcg/hr (Safe), NOT 50 mcg/hr.
10. Methadone & Infusion Logic Refinement
Infusion Tool Fix: Corrected "Add to Daily MME" action for Fentanyl Drips. Now maps to fentanyl_drip (0.12 factor) instead of generic fentanyl (0.3 factor), preventing massive MME inflation.
Methadone Elderly Logic: Removed the hardcoded 20:1 Ratio Clamp for elderly patients with 60-200 MME input. This logic previously under-dosed patients by 5x (5mg vs 25mg). Logic now relies on standard tiered ratios (Ratio 4-8) combined with cross-tolerance reduction instructions.
Verification Steps (Added)
Infusion Link:
Calc: Fentanyl Drip 100mcg/hr.
Click "Add to Calculator". Verify MME aligns with Drip estimate (~288), NOT ~720.
Methadone Elderly:
Input: 100mg Morphine PO. Age: 75.
Verify Methadone output is reasonable per NCCN (e.g. Ratio 8 = ~12.5mg), NOT clipped to 5mg (20:1).
11. UI Visual Refinement (Selection Controls)
Refactored
SelectionView.swift
:
Touch Targets: Increased padding (px-4 py-3) and enforced min-height 44px for accessibility.
Icons: Added Checkmark icons to Grid buttons with fixed 20x20 sizing and 8px gap.
Typography: Improved text wrapping with relaxed leading (lineSpacing(2)).
Motion: Added shadow-sm and ease-out animations for polish.
12. Active Drug Row Logic Refinement
Refactored ActiveMedicationRow:
Alignment: Vertically centered drug names with input fields for visual balance.
Input Field: Added distinct bg-gray-50 (or theme equivalent), rounded corners, and focus states.
Separation: Switched from Card style to List style with dividers (border-b) for cleaner information density.
Units: Fixed right-alignment for unit labels (mg/mcg) to ensure visibility.
13. Generated Note UI Polish
Refactored
RiskAssessmentView.swift
 (Consult Note):
Typography: Applied font-mono and text-sm (14px) with font-medium weight for EMR-like appearance.
Readability: Increased contrast with text-gray-800 equivalent (#333).
Container: Wrapped note in a bg-gray-50 box with rounded corners and a subtle border.
Feedback: Added "Copied!" validation state (Green Checkmark) for 2 seconds after tapping the Copy button.
14. Stress Test Validation (Final Audit)
Objective: Validation of critical Clinical Safety logic via ValidationRunner.
Scope: MME Accuracy, Methadone Safety, OUD Protocols, Transparency.
Results:
MME Calculator Accuracy: 100% PASS (7/7 Checks).
Fix 1 (M2): Updated Fentanyl Patch factor to 2.4x (CDC 2022) (60 MME/25mcg) vs outdated 2.0x.
Fix 2 (R1): Added explicit Hydromorphone IV target generation logic (Factor 20 / ~6.7mg Ratio).
Methadone Safety Engine: 100% PASS (11/11 Checks).
Fix 3 (MP2): Corrected Standard Ratio expectation (8:1 -> 12.5mg) to align with NCCN guidelines.
Fix 4 (M-Safety-7): Verified Manual Reduction Floor logic (7.5mg vs 5.0mg).
OUD Protocol Logic: 100% PASS (13/13 Checks).
Fix 5 (O4): Corrected "High-Dose Initiation" trigger to rely on High Tolerance (Fentanyl) rather than just ER Setting.
Fix 6 (O10): Fixed "Bridge Script" casing mismatch in verification logic.
Status: Critical systems are Green. (Minor failures in legacy Assessment/Suzetrigine logic noted for future sprint).

Legal Guardrail Implementation Walkthrough
I have successfully implemented the "Legal Guardrail" feature, ensuring that users must actively acknowledge the clinical disclaimer before accessing the application.

Changes Created

1. New Feature: Onboarding View
I created
AnalgesiaTool/Features/Onboarding/OnboardingView.swift
. This view includes:

Professional Use Warning: Clearly states the tool is for licensed professionals.
No Medical Advice Disclaimer: Emphasizes that estimates are educational.
Safety Limitation: Reminds users to verify with a pharmacist.
Active Acknowledgement: A toggle ("I am a licensed clinician...") that must be enabled to unlock the "Enter Application" button.
Persistence: Uses @AppStorage to remember if the user has accepted the liability.
2. App Integration
I modified
AnalgesiaTool/App/AnalgesiaToolApp.swift
 to:

Check the @AppStorage("hasAcceptedLiability_v1") key on app launch.
Present OnboardingView as a .fullScreenCover if the user has not yet accepted terms.
Verification
I performed a code review of the implemented files to ensure:

Persistence Logic: The hasAcceptedLiability key is consistent between the App and the View.
Binding: The $showOnboarding binding is correctly passed to dismiss the modal upon acceptance.
UI/UX: The layout matches the specifications provided, including the "glass box" transparency style and required disclaimers.
The app now has the "Professional Wrapper" required for TestFlight distribution.

1. Note Generator Logic
I updated
AnalgesiaTool/Core/Services/NoteGenerator.swift
 to handle missing age values gracefully.

Logic: If age is empty, it now defaults to "Adult" instead of displaying weird output (e.g., "??" or "yo").
Result: "Adult Female" instead of "Female" or "yo Female".
4. Drug Card Layout
I updated
AnalgesiaTool/Features/Library/Pharmacy/DrugMonographView.swift
 to refine the layout.

Boxed Warning: Moved from the top header to the bottom footer (below Citations) to deprioritize alarm fatigue while maintaining safety compliance.
Data Visibility: Verified that IV and PO fields (Onset, Duration, Bioavailability) are conditionally rendered and only appear if the specific drug has data for that route.
